📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti-DKK1 therapeutic DKN-01. (2023)

First Author: Jarman EJ

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/liv.15383

PubMed Identifier: 35924447

Publication URI: http://europepmc.org/abstract/MED/35924447

Type: Journal Article/Review

Volume: 43

Parent Publication: Liver international : official journal of the International Association for the Study of the Liver

Issue: 1

ISSN: 1478-3223